BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Authors » Tamra Sami

Tamra Sami

Articles

ARTICLES

Taking inspiration from Star Trek, Btr develops infrared diagnostic technology

Feb. 4, 2019
By Tamra Sami

Australia's Invion to enter clinic with photosensitizer drug to treat melanoma

Jan. 30, 2019
By Tamra Sami
PERTH, Australia – Like many Aussie companies, Invion Ltd. started out with some assets that it had a difficult time progressing forward, and it ended up remaking itself into a completely different company with new assets. Now, Melbourne-headquartered Invion plans to enter the clinic early this year with a photosensitizer therapy to treat melanoma.
Read More

Australia's Actinogen tackles Alzheimer's disease by inhibiting excess cortisol in the brain

Jan. 30, 2019
By Tamra Sami
PERTH, Australia – Stress is often a factor that contributes to many conditions ranging from psoriasis to irritable bowel syndrome, but it also has an effect on the brain, and recent evidence has shown that stress may be involved in accelerating the onset of Alzheimer's disease as well as worsening the course of the disease.
Read More

Australia gears up to implement formal GCP inspections program

Jan. 30, 2019
By Tamra Sami
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is launching a pilot good clinical practices (GCP) program in the hopes of launching a routine GCP inspections program.
Read More

Australia's Neuclone poised to disrupt pharma market with broad pipeline of biosimilars

Jan. 30, 2019
By Tamra Sami
PERTH, Australia – Australia's Neuclone Pharmaceuticals Ltd. is developing a broad pipeline of biosimilars, and it plans on being a big disrupter to the global pharma market.
Read More

Australia's Actinogen tackles Alzheimer's disease by inhibiting excess cortisol in the brain

Jan. 29, 2019
By Tamra Sami
PERTH, Australia – Stress is often a factor that contributes to many conditions ranging from psoriasis to irritable bowel syndrome, but it also has an effect on the brain, and recent evidence has shown that stress may be involved in accelerating the onset of Alzheimer's disease as well as worsening the course of the disease.
Read More

Sienna Cancer Diagnostics expands footprint to Asia as it looks to expand pipeline

Jan. 28, 2019
By Tamra Sami

Australia's Neuclone poised to disrupt pharma market with broad pipeline of biosimilars

Jan. 28, 2019
By Tamra Sami
PERTH, Australia – Australia's Neuclone Pharmaceuticals Ltd. is developing a broad pipeline of biosimilars, and it plans on being a big disrupter to the global pharma market.
Read More

Australia gears up to implement formal GCP inspections program

Jan. 24, 2019
By Tamra Sami

Australia gears up to implement formal GCP inspections program

Jan. 24, 2019
By Tamra Sami
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is launching a pilot good clinical practices (GCP) program in the hopes of launching a routine GCP inspections program.
Read More
View All Articles by Tamra Sami

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing